• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NewGenIVF Announces Strategic Investment Agreement with Tech Veteran Andy Cheung-Led K25.ai, an AI-Powered Live-Streaming Prediction Market, at US$100 Million Valuation

    5/21/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care
    Get the next $NIVF alert in real time by email

    BANGKOK and SINGAPORE, May 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGenIVF" or the "Company"), a technology-driven, diversified growth company, today announced that it has entered into a strategic investment agreement with K25.ai, an APAC-focused AI-powered watch-to-predict platform led by Mr. Andy Cheung, former Chief Operating Officer of OKX and former Chief Executive Officer of Groupon Hong Kong.

    K25.ai is designed to combine artificial intelligence, live-streaming content, creator communities and prediction-based engagement into a watch-to-predict consumer platform for permitted APAC markets. The strategic relationship is intended to provide NewGenIVF with exposure to an emerging category at the intersection of AI-assisted information markets, live-streaming engagement, creator monetization and localized APAC content.

    Under the terms of the agreement, NewGenIVF will make an initial strategic investment of US$2 million in K25.ai at a US$100 million pre-money valuation, subject to the terms of the definitive agreements and applicable closing conditions. NewGenIVF has also received an option to increase its investment to up to US$10 million if exercised in full, subject to the terms of the definitive agreements.

    The closing of the investment, any issuance of NewGenIVF ordinary shares and any exercise of the option remain subject to the terms of the definitive agreements, applicable closing conditions, Nasdaq rules, shareholder approval requirements, if applicable, and other applicable legal and regulatory requirements.

    K25.ai: AI-Powered Live-Streaming Prediction Markets

    K25.ai is building a new consumer layer for prediction markets by combining real-time content, creator communities, AI-assisted event generation and prediction-based engagement. The platform is designed to allow users in permitted markets to watch live content, follow creators, participate in community discussions and engage with prediction events linked to sports, esports, entertainment, creator challenges, cultural events and other APAC-relevant moments.

    K25.ai's AI layer is intended to support the prediction-market lifecycle, including event discovery, market generation, live-content understanding, data extraction, outcome monitoring and resolution workflows. This model is designed to help creators, communities and event owners launch timely prediction events around live content, while transforming live streaming from passive viewing into a more interactive information market.

    Exclusive APAC Agency Partnership

    NewGenIVF will enter into an exclusive agency agreement to support the promotion and commercial development of K25.ai in Thailand, Singapore, Japan and other permitted APAC markets, excluding Mainland China, Hong Kong, Macau and other restricted jurisdictions. Under the arrangement, NewGenIVF is expected to earn commission based on gross profit generated from customers it introduces or directly services, creating a potential commercial revenue channel while leveraging the Company's regional network and commercial relationships.

    K25.ai's products and services will only be made available where legally permitted and, where required, subject to applicable licensing, registration, regulatory approvals or exemptions.

    Board Nomination

    In connection with the strategic relationship, K25.ai will nominate three independent non-executive director candidates for consideration by NewGenIVF's board, subject to applicable Nasdaq independence, eligibility, corporate governance, board approval and other legal requirements. Following any such appointments, NewGenIVF expects its board to expand from five to eight directors.

    Leadership of K25.ai

    K25.ai is led by Mr. Andy Cheung, a veteran technology and digital asset executive with experience scaling platforms across Web3, fintech, consumer internet and digital advertising. Mr. Cheung previously served as Chief Operating Officer of OKX, where he helped build and scale one of the world's leading digital asset exchanges. He also served as Chief Executive Officer of Groupon Hong Kong and as Head of Hong Kong of iClick Interactive Asia Group Limited, a digital marketing technology company formerly listed on Nasdaq under the ticker ICLK and now operating as Amber International Holding Limited under the ticker AMBR. He was also previously an Independent Director of Prenetics Global Limited, a Nasdaq-listed health sciences company under the ticker PRE.

    Strategic Rationale and Market Context

    NewGenIVF believes K25.ai is positioned at the intersection of several high-growth themes: AI-powered information markets, live streaming and creator monetization, watch-to-predict audience engagement, AI-assisted event generation and resolution workflows, and localized APAC content and community participation. NewGenIVF believes the investment and agency partnership provide strategic exposure to an emerging category in APAC, where localized prediction-based engagement remains meaningfully underserved compared with larger global markets.

    For market-context purposes only, based on selected publicly reported valuation references for larger global prediction-market companies and K25.ai management's internal analysis, K25.ai's US$100 million pre-money valuation represents approximately 0.27% of those selected reported valuation references. This comparison is not a forecast, target valuation, investment return expectation or representation that K25.ai is comparable to, or will achieve outcomes similar to, any other company. The selected references may involve companies with different jurisdictions, business models, regulatory status, operating history, financial condition, user base and market dynamics.

    Management Commentary

    "This strategic investment provides NewGenIVF with exposure to the convergence of AI, live streaming, creator monetization and prediction-based information markets," said Mr. Alfred Siu Wing Fung, Founder, Chairman and Chief Executive Officer of NewGenIVF. "K25.ai's AI-powered watch-to-predict model creates a differentiated way for audiences to engage with live content in permitted APAC markets. The exclusive agency partnership is designed to create commercial opportunities through our regional network, while the investment provides exposure to the long-term development of this emerging category."

    "We are pleased to welcome NewGenIVF as a strategic shareholder and APAC commercial partner," said Mr. Andy Cheung, Founder of K25.ai. "K25.ai is being built for a new generation of interactive markets, where AI can help convert live content, creator moments and community attention into real-time prediction events. By combining AI-assisted market generation, live streaming, creator-led distribution and localized APAC content, we believe K25.ai can help define the next generation of watch-to-predict information markets in permitted markets."

    Geographic Restrictions

    K25.ai is not offered to U.S. persons or to users located in Mainland China, Hong Kong, Macau or other restricted jurisdictions. K25.ai intends to operate in accordance with applicable laws and regulations in the markets where it is made available. K25.ai's products and services will only be launched or made available in jurisdictions where such activities are legally permitted and, where applicable, subject to required licensing, registration, regulatory approvals or exemptions.

    About NewGenIVF Group Limited

    NewGenIVF Group is a tech-forward, diversified, multi-jurisdictional growth company pursuing opportunities across real estate development, digital asset innovation and reproductive health solutions. The Company operates through "NewGenProperty," focused on real estate development projects in the UAE's Ras Al Khaimah Emirate; "NewGenDigital," focused on digital asset and DeFi solutions; and "NewGenSup," focused on health and longevity products and solutions. NewGenIVF's legacy business involves IVF and assisted reproductive treatment services across Asia. To learn more, visit www.nivf.global. The information contained on, or accessible through, NewGenIVF's website is not incorporated by reference into this press release and should not be considered part of this press release.

    About K25.ai

    K25.ai is an APAC-focused AI-powered live-streaming and watch-to-predict platform. The platform combines real-time content, creator communities, AI-assisted event generation and prediction markets to transform live streaming from passive viewing into an interactive information market. Through K25.ai, users in permitted markets can watch live content, follow creators, participate in community discussions and engage with prediction events linked to real-world outcomes, sports, esports, entertainment, creator challenges and culturally relevant APAC events. K25.ai uses AI-assisted tools to support event creation, content analysis, data extraction, outcome monitoring and resolution workflows. K25.ai is not offered to U.S. persons or to users located in Mainland China, Hong Kong, Macau or other restricted jurisdictions.

    Forward-Looking Statements

    This press release contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995.

    These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "outlook," "would," "may," "potential," and similar statements. Without limiting the generality of the foregoing, forward-looking statements in this press release include, but are not limited to, statements regarding: the strategic investment by the Company in K25.ai, including the entry into and execution of definitive agreements, the anticipated completion of closing, and the satisfaction of closing conditions; the option to invest up to an additional approximately US$10 million; statements concerning any issuance of NewGenIVF shares; the exclusive APAC agency partnership, including the scope of permitted markets, the commercial terms, the commission economics and the expected revenue opportunity from customers introduced or serviced by the Company; board nomination rights; the commercial development of K25.ai; the AI-native watch-to-predict model, live streaming engagement, creator monetization, AI-assisted event generation and resolution workflows; market opportunity, including statements that K25.ai addresses a "meaningfully underserved market opportunity" and statements characterizing the partnership as exposure to "high-growth themes" at the intersection of AI, live streaming, creator monetization and prediction-based information markets; valuation references, including the US$100 million pre-money valuation, which reflects a negotiated valuation between the parties and is not based on any independent valuation, fairness opinion or third-party analysis; geographic restrictions and the ability of K25.ai to offer its services in permitted APAC markets; statements about the Company being a "tech-forward," "diversified," "multi-jurisdictional" and/or "high-growth" entity and statements regarding its ability to drive "sustainable growth" and "high ROI" across real estate development, digital asset management and reproductive health solutions; statements regarding the Company's NewGenProperty, NewGenDigital and NewGenSup business divisions and the Company's positioning to capitalize on the convergence of real estate, healthcare and digital asset opportunities; and expectations regarding future growth and performance.

    These forward-looking statements are based on current expectations, estimates, projections and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, among others, market conditions, regulatory developments (including evolving regulation of prediction-based products, online gaming, digital assets and AI-enabled services in APAC jurisdictions), competition, execution risk, user and creator adoption, platform engagement, liquidity and financing risks, Nasdaq compliance requirements, the ability to satisfy closing conditions, the ability to complete or implement definitive documentation, the risk that definitive agreements may not be entered into on the terms reflected in the binding term sheet or at all, the ability to exercise the option on expected terms or at all, the ability to obtain any required licensing, registration, regulatory approvals or exemptions, the risk that K25.ai or the Company may be unable to offer or commercialize prediction-based products in one or more APAC jurisdictions, the risk that the agency partnership may not generate the level of commissions or revenue currently anticipated by the parties, the risk that K25.ai's valuation may not be realized and may decline, including in subsequent financing rounds, the risk that any K25.ai-nominated director candidates may not satisfy applicable independence requirements, and the risk that the Company's broader business strategy across real estate development, digital asset management and reproductive health solutions may not deliver the "sustainable growth" or "high ROI" described in this press release, geographic restrictions and other risks described in the Company's filings with the U.S. Securities and Exchange Commission.

    All information provided in this press release is as of the date of this press release. The Company undertakes no obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required by applicable law.

    Contacts

    NewGen Investor Relations Contact

    ICR, LLC

    Robin Yang

    Phone: +1 (212) 537-3847

    Email: NewgenivfIR@icrinc.com

    K25.ai Media Contact

    media@k25.ai

    K25.ai Investor Relations Contact

    ir@k25.ai



    Get the next $NIVF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NIVF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NIVF
    SEC Filings

    View All

    SEC Form 6-K filed by NewGenIvf Group Limited

    6-K - NewGenIvf Group Ltd (0001981662) (Filer)

    6/4/26 8:30:11 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 6-K filed by NewGenIvf Group Limited

    6-K - NewGenIvf Group Ltd (0001981662) (Filer)

    5/28/26 8:49:43 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 6-K filed by NewGenIvf Group Limited

    6-K - NewGenIvf Group Ltd (0001981662) (Filer)

    5/21/26 8:31:37 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    K25.ai Secures US$6 Million Strategic Investment from Nasdaq-Listed NewGen at US$100 Million Valuation; Co-Founders to Join Board and Lead Digital Asset Treasury Strategy

    SINGAPORE, June 4, 2026 /PRNewswire/ -- K25.ai, an AI-native livestreaming and watch-to-predict prediction market platform purpose-built for Asia-Pacific, today announced that NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen") has committed an additional US$4 million strategic investment in K25.ai, bringing NewGen's total strategic investment in K25.ai to US$6 million at an implied valuation of US$100 million and further deepening the partnership between the two companies. The additional investment strengthens NewGen's strategic exposure to K25.ai and underscores growing recognition of K25.ai's positioning at the convergence of AI, livestreaming, digital assets and prediction markets. As part

    6/4/26 9:00:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury Strategy

    NewGen's 6% Stake in K25.ai Now Valued at US$6 MillionCompany will Leverage Expertise of K25.ai's Andy Cheung to Develop Digital Asset Treasury Strategy BANGKOK, June 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced it has exercised its top-up option to acquire an additional 4% equity interest in AI-native livestreaming prediction market platform K25.ai, raising its total holding to 6%. The additional US$4 million investment, which supplements an initial US$2 million investment announced in May 2026, is split evenly between cash and newly issued NewGen Class A ordinary shares.

    6/4/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGen Executes Share Purchase Agreement and Obtains Exclusive APAC Agency Rights with K25.ai, an AI-Powered Prediction Market Led by Industry Veteran Andy Cheung

    NewGen executes Share Purchase Agreement to acquire an initial 2% equity interest in K25.ai, with the right to invest up to 10% in totalNewGen also executes Exclusive Agency Agreement with K25.ai, appointing NewGen as K25.ai's exclusive agency partner for selected permitted APAC markets, creating a potential asset-light commercial growth channelAccording to media reports citing Bernstein research, prediction market volumes could reach approximately US$1 trillion by 2030 as the category evolves into broader information markets across sports, crypto, politics, macroeconomic and event-driven contractsAPAC market tailwinds across mobile, digital economy, gaming, esports, live-streaming, social v

    5/28/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp sold $50,722 worth of shares (64,945 units at $0.78), decreasing direct ownership by 78% to 18,134 units (SEC Form 4)

    4 - NewGenIvf Group Ltd (0001981662) (Issuer)

    6/8/26 3:11:25 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    Director Siu Wing Fung Alfred exercised 56,851 units of Class B Ordinary Shares at a strike of $0.00, increasing direct ownership by 189,503% to 56,881 units (SEC Form 4)

    4 - NewGenIvf Group Ltd (0001981662) (Issuer)

    6/5/26 11:14:50 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    Director Fong Hei Yue Tina exercised 56,851 units of Class B Ordinary Shares at a strike of $0.00, increasing direct ownership by 145,772% to 56,890 units (SEC Form 4)

    4 - NewGenIvf Group Ltd (0001981662) (Issuer)

    6/5/26 11:14:20 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp bought $32,000 worth of shares (34,756 units at $0.92), increasing direct ownership by 72% to 83,079 units (SEC Form 4)

    4 - NewGenIvf Group Ltd (0001981662) (Issuer)

    6/4/26 4:08:25 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    Large owner Hrt Financial Lp bought $161,919 worth of shares (165,534 units at $0.98) (SEC Form 4)

    4 - NewGenIvf Group Ltd (0001981662) (Issuer)

    5/27/26 1:19:20 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Leadership Updates

    Live Leadership Updates

    View All

    NewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury Strategy

    NewGen's 6% Stake in K25.ai Now Valued at US$6 MillionCompany will Leverage Expertise of K25.ai's Andy Cheung to Develop Digital Asset Treasury Strategy BANGKOK, June 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced it has exercised its top-up option to acquire an additional 4% equity interest in AI-native livestreaming prediction market platform K25.ai, raising its total holding to 6%. The additional US$4 million investment, which supplements an initial US$2 million investment announced in May 2026, is split evenly between cash and newly issued NewGen Class A ordinary shares.

    6/4/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NIVF Appoints Award-Winning Web3 Leader Joshua Chu to Spearhead Tokenization Strategy and Formally Engages Evident Capital to Launch Up to USD 30 Million in Tokenized Bonds by Q1, Outlining 2026 Value Catalysts

    BANGKOK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (("NewGen" or the "Company, NASDAQ:NIVF), a technology-driven company building a diversified ecosystem across fertility technology, digital assets, and real estate development, today announced the appointment of award-winning Web3 legal and regulatory specialist Joshua Chu as Senior Counsel to lead the Group's tokenization strategy, alongside the formal engagement of Evident Capital, Hong Kong's first fully integrated, SFC-licensed tokenization and alternative assets platform, to support the launch of NIVF's inaugural tokenized bond issuance of up to USD 30 million targeted for completion by the first quarter of 2026. As S

    1/21/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    NewGenDigital Appointed as SAXA Inc.'s Agent for Tokenization of US$100 Million of Gold-backed Assets

    Service agreement with SAXA, Inc. appoints NewGenDigital as SAXA's worldwide tokenization agent, strengthening cooperation between the two companies ahead of proposed reverse merger Value of tokenized assets could be expanded to US$1 billion under the terms of the agreement; NewGenDigital to earn 5% commission on assets sold BANGKOK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced that its subsidiary, NewGenD

    11/5/25 9:00:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Financials

    Live finance-specific insights

    View All

    NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress

    NewGen records strong balance sheet with total assets of US$32.7 million Net profit attributable to shareholders of the Company of US$9.9 million BANGKOK, May 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today outlined several highlights of its fiscal year 2025 results and the steady progress of its continued strategic transformation. More information on NewGen's results can be found in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, (the "2025 Annual Report") which was filed with the U.S. Securities and Exchange Commission (the "SEC") in April 2026. The ful

    5/4/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    $NIVF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    12/5/24 8:23:57 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    11/13/24 9:19:27 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    10/10/24 3:39:26 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care